Restricted Emergency Use
- All
- News
- Videos
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Drug Firm Hetero Gets Approval To Produce, Sell Sputnik Light Vaccine
Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
-
Covovax Gets Emergency Use Approval For Children Above 12 Years
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
Covaxin Gets WHO Approval, Finally
The WHO has granted Covaxin an emergency use listing, sources said Wednesday, which means the 'made-in-India' vaccine will be recognised by other countries and Indians who received the shot need not self-quarantine or face restrictions abroad.
-
Serum Institute Seeks Drug Regulator's Approval For Covovax Vaccine: Report
The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufacture COVID-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said.
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
1st Lot Of Russian COVID-19 Vaccine Sputnik V Likely In India By May End
Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, today said it expects the first lot of stock from Russian Direct Investment Fund by May end.
-
Decision On Emergency Use Applications For Foreign Covid Vaccines In 3 Days
India's drug regulator will take a decision on applications seeking approval for restricted emergency use of foreign produced COVID-19 vaccines within three working days from the date of submission, the government said on Thursday.
-
Covid Vaccine Recipients Will Not Get To Choose From 2 Options For Now: Centre
The government hinted on Tuesday that for now, the COVID vaccine recipients will not have the option to choose from the two vaccines recently approved for restricted emergency use in India.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Centre Has Not Banned Export Of Any Covid Vaccine: Union Health Secretary
The Union government has not banned the export of any COVID-19 vaccine that has been granted restricted emergency use approval by the drug regulator, the Health Ministry said today, while urging the media to be on guard against the spread of such misinformation.
-
"Maharashtra Wants Some Clarifications On Vaccines From Centre": Minister
The Maharashtra government will seek some clarifications from the Centre on the two COVID-19 vaccines approved for the restricted emergency use before launching a mass inoculation drive in the state, Health Minister Rajesh Tope said on Tuesday.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
-
Serum Institute's Covid Vaccine Covovax Cleared For 7-11 Age Group
The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said.
-
Drug Firm Hetero Gets Approval To Produce, Sell Sputnik Light Vaccine
Drug firm Hetero on Monday said its biologics arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and sell Sputnik Light for restricted emergency use in India.
-
Covovax Gets Emergency Use Approval For Children Above 12 Years
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
Covaxin Gets WHO Approval, Finally
The WHO has granted Covaxin an emergency use listing, sources said Wednesday, which means the 'made-in-India' vaccine will be recognised by other countries and Indians who received the shot need not self-quarantine or face restrictions abroad.
-
Serum Institute Seeks Drug Regulator's Approval For Covovax Vaccine: Report
The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufacture COVID-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said.
-
"3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children
Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).
-
1st Lot Of Russian COVID-19 Vaccine Sputnik V Likely In India By May End
Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, today said it expects the first lot of stock from Russian Direct Investment Fund by May end.
-
Decision On Emergency Use Applications For Foreign Covid Vaccines In 3 Days
India's drug regulator will take a decision on applications seeking approval for restricted emergency use of foreign produced COVID-19 vaccines within three working days from the date of submission, the government said on Thursday.
-
Covid Vaccine Recipients Will Not Get To Choose From 2 Options For Now: Centre
The government hinted on Tuesday that for now, the COVID vaccine recipients will not have the option to choose from the two vaccines recently approved for restricted emergency use in India.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Centre Has Not Banned Export Of Any Covid Vaccine: Union Health Secretary
The Union government has not banned the export of any COVID-19 vaccine that has been granted restricted emergency use approval by the drug regulator, the Health Ministry said today, while urging the media to be on guard against the spread of such misinformation.
-
"Maharashtra Wants Some Clarifications On Vaccines From Centre": Minister
The Maharashtra government will seek some clarifications from the Centre on the two COVID-19 vaccines approved for the restricted emergency use before launching a mass inoculation drive in the state, Health Minister Rajesh Tope said on Tuesday.
